Paul Wang to Neoplasms
This is a "connection" page, showing publications Paul Wang has written about Neoplasms.
Connection Strength
0.855
-
Korotcov AV, Ye Y, Chen Y, Zhang F, Huang S, Lin S, Sridhar R, Achilefu S, Wang PC. Glucosamine-linked near-infrared fluorescent probes for imaging of solid tumor xenografts. Mol Imaging Biol. 2012 Aug; 14(4):443-51.
Score: 0.219
-
Liang XJ, Chen C, Zhao Y, Wang PC. Circumventing tumor resistance to chemotherapy by nanotechnology. Methods Mol Biol. 2010; 596:467-88.
Score: 0.183
-
Gong N, Zhang Y, Teng X, Wang Y, Huo S, Qing G, Ni Q, Li X, Wang J, Ye X, Zhang T, Chen S, Wang Y, Yu J, Wang PC, Gan Y, Zhang J, Mitchell MJ, Li J, Liang XJ. Proton-driven transformable nanovaccine for cancer immunotherapy. Nat Nanotechnol. 2020 12; 15(12):1053-1064.
Score: 0.097
-
Chen S, Yang K, Tuguntaev RG, Mozhi A, Zhang J, Wang PC, Liang XJ. Targeting tumor microenvironment with PEG-based amphiphilic nanoparticles to overcome chemoresistance. Nanomedicine. 2016 Feb; 12(2):269-86.
Score: 0.069
-
Meng J, Liu Y, Gao S, Lin S, Gu X, Pomper MG, Wang PC, Shan L. A bivalent recombinant immunotoxin with high potency against tumors with EGFR and EGFRvIII expression. Cancer Biol Ther. 2015; 16(12):1764-74.
Score: 0.065
-
Zhang J, Li C, Zhang X, Huo S, Jin S, An FF, Wang X, Xue X, Okeke CI, Duan G, Guo F, Zhang X, Hao J, Wang PC, Zhang J, Liang XJ. In vivo tumor-targeted dual-modal fluorescence/CT imaging using a nanoprobe co-loaded with an aggregation-induced emission dye and gold nanoparticles. Biomaterials. 2015 Feb; 42:103-11.
Score: 0.065
-
Huang K, Ma H, Liu J, Huo S, Kumar A, Wei T, Zhang X, Jin S, Gan Y, Wang PC, He S, Zhang X, Liang XJ. Size-dependent localization and penetration of ultrasmall gold nanoparticles in cancer cells, multicellular spheroids, and tumors in vivo. ACS Nano. 2012 May 22; 6(5):4483-93.
Score: 0.054
-
Yin JJ, Lao F, Meng J, Fu PP, Zhao Y, Xing G, Gao X, Sun B, Wang PC, Chen C, Liang XJ. Inhibition of tumor growth by endohedral metallofullerenol nanoparticles optimized as reactive oxygen species scavenger. Mol Pharmacol. 2008 Oct; 74(4):1132-40.
Score: 0.041
-
Liang XJ, Yin JJ, Zhou JW, Wang PC, Taylor B, Cardarelli C, Kozar M, Forte R, Aszalos A, Gottesman MM. Changes in biophysical parameters of plasma membranes influence cisplatin resistance of sensitive and resistant epidermal carcinoma cells. Exp Cell Res. 2004 Feb 15; 293(2):283-91.
Score: 0.030
-
Zhang J, Li S, An FF, Liu J, Jin S, Zhang JC, Wang PC, Zhang X, Lee CS, Liang XJ. Self-carried curcumin nanoparticles for in vitro and in vivo cancer therapy with real-time monitoring of drug release. Nanoscale. 2015 Aug 28; 7(32):13503-10.
Score: 0.017
-
Kumar A, Chen F, Mozhi A, Zhang X, Zhao Y, Xue X, Hao Y, Zhang X, Wang PC, Liang XJ. Innovative pharmaceutical development based on unique properties of nanoscale delivery formulation. Nanoscale. 2013 Sep 21; 5(18):8307-8325.
Score: 0.015